Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis.

Saved in:
Bibliographic Details
Title: Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis.
Authors: Labuda SM; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30329, USA., Seaworth B; Heartland National Tuberculosis Center, San Antonio, TX, USA., Dasgupta S; Los Angeles County Department of Public Health, Los Angeles, CA, USA., Goswami ND; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30329, USA. Electronic address: nef7@cdc.gov.
Corporate Authors: BPaL Accelerated Monitoring Project Team
Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Feb; Vol. 12 (2), pp. e5-e6. Date of Electronic Publication: 2023 Nov 30.
Publication Type: Letter
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-2619
DOI:10.1016/S2213-2600(23)00426-5